Tag Archives: NRAS melanoma

December, 2015

  • 16 December

    Array Biopharma’s Melanoma Drug Succeeds in Late-Stage Study

    BOULDER, Colo., Dec. 16, 2015 /PRNewswire/ — Array BioPharma (ARRY) today reported top-line results from the ongoing Phase 3 clinical trial of binimetinib in patients with advanced NRAS-mutant melanoma, known as the NEMO trial.  The study met its primary endpoint of improving progression-free survival (PFS) compared with dacarbazine treatment. The median …